CurrentEndo
Get Weekly

CurrentEndo coverage · page 40 of 55

Diabetes, Obesity and Metabolism

Briefs 1,561–1,600 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1‐year real‐world assessment

    Cohort studyTechnology

  2. Diabetes Obes Metab

    Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps

    Meta-analysisTechnology

  3. Diabetes Obes Metab

    Circulating small non‐coding RNAs are associated with the insulin‐resistant and obesity‐related type 2 diabetes clusters

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Efficacy of Aspirin for primary prevention among adults with high‐risk type 2 diabetes in the ACCORD trial

    Secondary analysisT2D & other

  5. Diabetes Obes Metab

    Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes

    Cross-sectional studyT1D

  6. Diabetes Obes Metab

    Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training

    Randomized controlled trialLipids & liver

  7. Diabetes Obes Metab

    Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study

    Randomized controlled trialT2D & other

  8. Diabetes Obes Metab

    The interaction effect between BMI , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China

    Cohort studyEndocrine cancer

  9. Diabetes Obes Metab

    Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study

    Cohort studyT2D & other

  10. Diabetes Obes Metab

    Associations of body mass index, waist circumference and the weight‐adjusted waist index with daily living ability impairment in older Chinese people: A cross‐sectional study of the Chinese Longitudinal Healthy Longevity Survey

    Cross-sectional studyObesity

  11. Diabetes Obes Metab

    Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial

    Secondary analysisT2D & other

  12. Diabetes Obes Metab

    The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035

    Secondary analysisObesity

  13. Diabetes Obes Metab

    Reversal of insulin resistance in people with obesity by lifestyle‐induced weight loss does not impact the proportion of circulating 12α‐hydroxylated bile acids

    Cohort studyObesity

  14. Diabetes Obes Metab

    Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus

    Case-control studyDiabetes in pregnancy

  15. Diabetes Obes Metab

    The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  16. Diabetes Obes Metab

    Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management

    Cohort studyT2D & other

  17. Diabetes Obes Metab

    Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors

    Cohort studyComplications

  18. Diabetes Obes Metab

    Incretin‐based therapy and the risk of diabetic foot ulcers and related events

    Cohort studyT2D & other

  19. Diabetes Obes Metab

    Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials

    Meta-analysisT2D & other

  20. Diabetes Obes Metab

    Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes

    Randomized controlled trialT2D & other

  21. Diabetes Obes Metab

    The association of diabetes with progression of sleep‐disordered breathing based on a prospective cohort

    Cohort studyComplications

  22. Diabetes Obes Metab

    Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life

    Cohort studyObesity

  23. Diabetes Obes Metab

    Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery

    Cohort study

  24. Diabetes Obes Metab

    Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery

    Cohort studyObesity

  25. Diabetes Obes Metab

    Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials

    Meta-analysisT2D & other

  26. Diabetes Obes Metab

    Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data

    Secondary analysisT2D & other

  27. Diabetes Obes Metab

    Effects of light‐intensity physical activity on cardiometabolic parameters in young adults with overweight and obesity: The SED ‐ ACT randomized controlled crossover trial

    Randomized controlled trialObesity

  28. Diabetes Obes Metab

    Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes

    Cross-sectional studyT1D

  29. Diabetes Obes Metab

    The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial

    Randomized controlled trialT2D & other

  30. Diabetes Obes Metab

    Decreased complexity of glucose time series index associated with adverse pregnancy outcomes in gestational diabetes mellitus

    Cohort studyDiabetes in pregnancy

  31. Diabetes Obes Metab

    Interactions between age, sex and visceral adipose tissue on brain ageing

    Cross-sectional study

  32. Diabetes Obes Metab

    Real‐life hypoglycaemia partially blunts the inflammatory response to experimental hypoglycaemia in people with type 1 diabetes

    Secondary analysisT1D

  33. Diabetes Obes Metab

    Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all‐cause mortality in adults, compared with bisphosphonates: An analysis of real‐world, cohort data, with a systematic review and meta‐analysis

    Meta-analysisBone & mineral

  34. Diabetes Obes Metab

    Association between low cognitive performance and diabetes‐related health indicators across racial and ethnic groups in adults with diabetes

    Cross-sectional studyT2D & other

  35. Diabetes Obes Metab

    Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial

    Secondary analysisT2D & other

  36. Diabetes Obes Metab

    Physical activity in relation to metabolic health and obesity: The Feel4Diabetes study

    Cohort studyObesity

  37. Diabetes Obes Metab

    Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis

    Meta-analysisTechnology

  38. Diabetes Obes Metab

    Genetic variants of LEAP2 are associated with anthropometric traits and circulating insulin‐like growth factor‐1 concentration: A UK Biobank study

    Diagnostic or prognostic studyObesity

  39. Diabetes Obes Metab

    Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes

    Case-control studyT1D

  40. Diabetes Obes Metab

    Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study

    Cross-sectional studyLipids & liver

All 2,200 Briefs in ExploreShowing Briefs 1,561–1,600 of 2,200, newest first